Savara Inc. Securities Class Action Lawsuit Alert: Notice to Investors

Strategic Insights -

Investors who purchased Savara Inc. securities between March 7, 2024, and May 23, 2025, may be entitled to compensation due to alleged false and misleading statements made by the company. A class action lawsuit has been filed, and investors have until November 7, 2025, to join the suit. The Rosen Law Firm, a global investor rights law firm, reminds investors of the lead plaintiff deadline.

Key Takeaways:

  • A class action lawsuit has been filed against Savara Inc. for alleged false and misleading statements made between March 7, 2024, and May 23, 2025.
  • Investors who purchased Savara securities during this time may be entitled to compensation without payment of any out-of-pocket fees or costs through a contingency fee arrangement.
  • The lead plaintiff deadline is November 7, 2025, and investors must move the Court by this date to serve as lead plaintiff.
  • The Rosen Law Firm, with a track record of success in leadership roles, represents investors throughout the globe and has achieved significant securities class action settlements.
  • The firm has been ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017 and has recovered hundreds of millions of dollars for investors.
  • The lawsuit alleges that defendants made false and/or misleading statements regarding the company's Biologics License Application (BLA) for MOLBREEVI, a clinical trial for a rare lung disease.

Statistics:

  • The lawsuit covers a period of approximately 1 year and 3 months (March 7, 2024, to May 23, 2025).
  • The lead plaintiff deadline is November 7, 2025.
  • The Rosen Law Firm has recovered over $438 million for investors in 2019 and has secured hundreds of millions of dollars for investors.

Sources:

  • Newsfile Corp. - October 25, 2025
  • The Rosen Law Firm, P.A. - 275 Madison Avenue, 40th Floor, New York, NY 10016
  • Laurence Rosen, Esq. - Phone: (212) 686-1060, Toll Free: (866) 767-3653, Fax: (212) 202-3827, Email: case@rosenlegal.com, Website: www.rosenlegal.com